Guillain-Barré syndrome and checkpoint inhibitor therapy: insights from pharmacovigilance data

Overview of attention for article published in BMJ Neurology Open, March 2024

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 public wall post.

There are increasing reports of cases of Guillain-Barré syndrome (GBS) as an adverse event of an Immune Checkpoint Inhibitor (ICI…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.